Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03289793
Other study ID # 69HCL15_0214
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2, 2017
Est. completion date September 9, 2019

Study information

Verified date October 2019
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims to assess the evolution of symptoms in ADHD children from 8 to 17 years, with various types of attention training.

Different groups A, B and C will be evaluated: the first with Neurofeedback training, the second with a similar training but not indexed on brain activity and the third without training.

30 patients will be randomly assigned to groups A and B according to a ratio 2:1.

Others patients who meet the same criteria but for logistical reasons cannot comply with the training constraints will be assigned to group C.

Children included in groups A and B will participate in training sessions (Neurofeedback and control training, respectively) as well as in four evaluation sessions. Children in group C will only participate in evaluation sessions (baseline control group).

Patients of groups A and B will be followed over 6 months: 4 months of training and a follow-up evaluation 2 months after training.

Patients of group C will be followed each 2 months for 6 months. This study uses electro-encephalography measures, serious video game, neuropsychological tests and questionnaires.

It also uses actigraphy measures to evaluate sleep quality.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date September 9, 2019
Est. primary completion date September 9, 2019
Accepts healthy volunteers No
Gender All
Age group 8 Years to 17 Years
Eligibility Inclusion Criteria:

- Children and teenagers aged from 8 to 17 years' old

- Children and teenagers with a deficit attention disorder with or without hyperactivity, in the mixed form or in a pure inattentive form according to Diagnostique et Statistique des troubles Mentaux (DSM)-V.

- Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) = 80 of WISC IV or V test, not older than two years.

- Children and teenagers without psychostimulant treatment

- Children and teenagers with psychostimulant treatment agreed to achieve a therapeutic break at each visit day and with a stable dose during all the study.

- Children and teenagers whose parents have agreed and signed informed consent form of the study.

Exclusion Criteria:

- Children aged less than 8 and teenagers are more than 18 years' old.

- Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) < 80 of WISC IV or V test, not older than two years.

- Children and teenagers with developmental disorder except "Dys" disorders.

- Children and teenagers with pure hyperactivity (without attentional deficit)

- Children and teenagers with epilepsy except benign epilepsies (without brain damage), free of crisis for two years and without treatment.

- Children and teenagers with ADHD with conduct disorders and aggression

- Children and teenagers with ADHD and Tourette's syndrome.

- Patients treated by anti / epilepsy or psychotropic treatments (with the exception of psychostimulant treatment).

- Patients with psychostimulant treatment and whose parents aren't agreed to achieve a therapeutic break at each visit day.

- Patients with visual deficiency uncorrectable with lenses or glasses.

Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder With Hyperactivity
  • Hyperkinesis

Intervention

Other:
Neurofeedback training
Children in group A will receive BCI-based training implemented through original P300-based controlled games. They will attend 30 1-hour long training sessions at a pace of 2 sessions per week. Each session includes: installation of the child, the EEG system and an eye-tracking system, a 5-minutes relaxation phase, a short EEG recording at rest, a brief reminder of the instructions, 30 minutes of training by playing video games and finally a time for the child to wash her/his hair. Moreover, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be answered.
Active Sham control
Children in group B will receive a training that is not based on brain activity, but in a blind fashion. They will attend 30 1-hour long training sessions at a pace of 2 sessions per week. Each session includes: installation of the child, setting up the EEG and eye-tracking systems, a 5-minutes relaxation phase, short EEG recording at rest, a brief reminder of the instructions, 30 minutes of video game based training and finally a time for the child to wash her/his hair. Besides, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be performed.
Baseline control group
The children included in this group will not receive any training. They only take part to the 4 neuropsychological sessions. Like others, they will attend 1 neuropsychological session every two months over six months.

Locations

Country Name City State
France Hospices Civils de Lyon Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the relative effect on symptoms of inattention between the two proposed training techniques, A and B, with the ADHD Rating Scale in children with ADHD Questions with odd numbers interested in the dimension "inattentive" will particularly be studied. The investigator expect an improvement in the type of score: ''ADHD-Inattentive'' children in group A compared to children in Group B. More specifically, he expect to improve responses to questions number 1,3,5,7,9,11,13,15 and 17. By definition, an evolving response would be to move from " 2=Often; 3=Very often" to " 1=Sometimes; 0=Rarely/Never". every two months over six months.
Secondary Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared every months over six months.
Secondary Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children Bron/Lyon Attention Stability test (BLAST) test will be performed ADHD children from groups A, B and C will be compared every months over six months.
Secondary Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children Wechsler Intelligence Scale for Children (WISC) subtests will be performed ADHD children from groups A, B and C will be compared every months over six months.
Secondary Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children Wechsler Intelligence Scale for Children (WISC) will be performed ADHD children from groups A, B and C will be compared every months over six months.
Secondary Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared every months over six months.
Secondary Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children Bron/Lyon Attention Stability test (BLAST) will be performed ADHD children from groups A, B and C will be compared every months over six months.
Secondary Compare the effects of the two types of trainings on the hyperactivity symptoms in ADHD children using neuropsychological assessments. ADHD Rating Scale (questions with even numbers), Test d'évaluation de l'Attention (TAP) and Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. CPT will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. CPT will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. CPT will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. TAP will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. BLAST will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared every two months over six months
Secondary Evaluate the impact of the trainings on the sleep quality in ADHD children. Sleep questionnaires will be distributed ADHD children in groups A, B and C will be compared. every two months over six months.
Secondary Evaluate the impact of the trainings on the sleep quality in ADHD children. The sleep data may also be collected using an actigraph (ancillary study). ADHD children in groups A, B and C will be compared. every two months over six months.
Secondary Evaluating the impact of the trainings on the quality of life in ADHD children. The Child Behavior CheckList (CBCL) questionnaire will be performed
Groups A, B and C will be compared.
every two months over six months
Secondary Evaluating the impact of the trainings on the quality of life in ADHD children. Information about the quality of life will be also collected in a logbook by family members and provided at each visit.
Groups A, B and C will be compared.
every two months over six months
See also
  Status Clinical Trial Phase
Completed NCT00202605 - Safety and Efficacy of SPD465 in Adults With ADHD Phase 2
Not yet recruiting NCT02677519 - A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Phase 4
Completed NCT02730572 - Concerta (Methylphenidate) -To-Generic Switch Study N/A
Completed NCT01681082 - Psychological Effects of Tai Chi Training N/A
Active, not recruiting NCT01330693 - Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy Phase 3
Completed NCT00830700 - Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study N/A
Completed NCT01012622 - An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) Phase 4
Completed NCT00626236 - Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems Phase 2
Completed NCT00598182 - Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study N/A
Completed NCT00381407 - Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00247572 - Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories Phase 2
Completed NCT00178503 - Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children Phase 2/Phase 3
Completed NCT00557011 - NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Phase 2
Completed NCT00218322 - Effectiveness of ATMX in Treating Adolescents With ADHD and SUD Phase 4
Completed NCT00118911 - Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder N/A
Completed NCT00071656 - Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I N/A
Active, not recruiting NCT00057668 - Preventing Behavior Problems in Children With ADHD Phase 2
Completed NCT00050050 - Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder Phase 1
Completed NCT00050622 - Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT00031395 - Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children Phase 3